These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19651236)

  • 41. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis.
    Sartori G; Cavazza A; Bertolini F; Longo L; Marchioni A; Costantini M; Barbieri F; Migaldi M; Rossi G
    Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of K-ras mutations in pancreatic tissue after fine needle aspirates.
    Pabst B; Arps S; Binmoeller K; Thul R; Walsemann G; Fenner C; Klapdor R
    Anticancer Res; 1999; 19(4A):2481-3. PubMed ID: 10470178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topographic analysis of K- ras mutations in histologically normal lung tissues and tumours of lung cancer patients.
    Keohavong P; Mady HH; Gao WM; Siegfried JM; Luketich JD; Melhem MF
    Br J Cancer; 2001 Jul; 85(2):235-41. PubMed ID: 11461083
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of c-K-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas.
    Shibata D; Almoguera C; Forrester K; Dunitz J; Martin SE; Cosgrove MM; Perucho M; Arnheim N
    Cancer Res; 1990 Feb; 50(4):1279-83. PubMed ID: 2404591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors.
    Younes N; Fulton N; Tanaka R; Wayne J; Straus FH; Kaplan EL
    Cancer; 1997 May; 79(9):1804-8. PubMed ID: 9128999
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical significance of ras oncogene activation in human lung cancer.
    Rodenhuis S; Slebos RJ
    Cancer Res; 1992 May; 52(9 Suppl):2665s-2669s. PubMed ID: 1562997
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of Raf-1 in human pancreatic adenocarcinoma.
    Berger DH; Jardines LA; Chang H; Ruggeri B
    J Surg Res; 1997 Apr; 69(1):199-204. PubMed ID: 9202670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reassessment of K-ras mutations at codon 12 by direct PCR and sequencing from tissue microdissection in human pancreatic adenocarcinomas.
    Aoki Y; Hosaka S; Tachibana N; Karasawa Y; Kawa S; Kiyosawa K
    Pancreas; 2000 Aug; 21(2):152-7. PubMed ID: 10975709
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutated c-K-ras in small pancreatic adenocarcinomas.
    Schaeffer BK; Glasner S; Kuhlmann E; Myles JL; Longnecker DS
    Pancreas; 1994 Mar; 9(2):161-5. PubMed ID: 8190717
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/Arf.
    Wang Y; Zhang Z; Lubet R; You M
    Oncogene; 2005 Apr; 24(18):3042-9. PubMed ID: 15846305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship of family cancer history to the expression of p53, p21WAF-1, HER-2/neu, and K-ras mutation in pancreatic adenocarcinoma.
    Dergham ST; Dugan MC; Arlauskas P; Du W; Vaitkevicius VK; Crissman JD; Sarkar FH
    Int J Pancreatol; 1997 Jun; 21(3):225-34. PubMed ID: 9322121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High K-ras mutation rates in goblet-cell-type adenocarcinomas of the lungs.
    Tsuchiya E; Furuta R; Wada N; Nakagawa K; Ishikawa Y; Kawabuchi B; Nakamura Y; Sugano H
    J Cancer Res Clin Oncol; 1995; 121(9-10):577-81. PubMed ID: 7559740
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glutathione S-transferase mu1 null genotype is associated with K-ras gene mutation in lung adenocarcinoma among smokers.
    Matsuzoe D; Hideshima T; Iwasaki A; Yoneda S; Kawahara K; Shirakusa T; Kimura A
    Carcinogenesis; 2001 Aug; 22(8):1327-30. PubMed ID: 11470766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A highly sensitive method for K-ras mutation detection is useful in diagnosis of gastrointestinal cancer.
    Puig P; Urgell E; Capellá G; Sancho FJ; Pujol J; Boadas J; Farré A; Lluís F; González-Sastre F; Mora J
    Int J Cancer; 2000 Jan; 85(1):73-7. PubMed ID: 10585586
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer: a baseline and 2-year repeat study.
    Pelosi G; Sonzogni A; Veronesi G; De Camilli E; Maisonneuve P; Spaggiari L; Manzotti M; Masullo M; Taliento G; Fumagalli C; Bellomi M; Travis WD; Kadivar M; Viale G
    Lung Cancer; 2008 Nov; 62(2):202-14. PubMed ID: 18450320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patterns of genetic alterations in pancreatic cancer: a pooled analysis.
    Blanck HM; Tolbert PE; Hoppin JA
    Environ Mol Mutagen; 1999; 33(2):111-22. PubMed ID: 10217065
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of proto-oncogenes in human and mouse lung tumors.
    Reynolds SH; Anderson MW
    Environ Health Perspect; 1991 Jun; 93():145-8. PubMed ID: 1773785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas.
    Smit VT; Boot AJ; Smits AM; Fleuren GJ; Cornelisse CJ; Bos JL
    Nucleic Acids Res; 1988 Aug; 16(16):7773-82. PubMed ID: 3047672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic mutations associated with cigarette smoking in pancreatic cancer.
    Blackford A; Parmigiani G; Kensler TW; Wolfgang C; Jones S; Zhang X; Parsons DW; Lin JC; Leary RJ; Eshleman JR; Goggins M; Jaffee EM; Iacobuzio-Donahue CA; Maitra A; Klein A; Cameron JL; Olino K; Schulick R; Winter J; Vogelstein B; Velculescu VE; Kinzler KW; Hruban RH
    Cancer Res; 2009 Apr; 69(8):3681-8. PubMed ID: 19351817
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [New molecular classification of colorectal cancer, pancreatic cancer and stomach cancer: Towards "à la carte" treatment?].
    Dreyer C; Afchain P; Trouilloud I; André T
    Bull Cancer; 2016; 103(7-8):643-50. PubMed ID: 27345450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.